# IBD_subtype_discovery
We developed a novel proof-of-concept dual-encoder deep learning model to predict inflammatory bowel disease progression using longitudinal multi-omics data from 130 patients and over 1,600 samples. Using Gaussian mixture modeling on trajectory features, we identified three molecularly distinct Crohnâ€™s disease subtypes and validated these findings with transcriptomic inflammation levels (p = 0.0017). Additionally, we discovered a high-risk subgroup representing 10% of patients with a 40% elevation in molecular inflammation, providing the potential for early treatment stratification and advancing precision medicine approaches in IBD. Future works including further cross-validation using more datasets, which would in turn enrich subtype results. 

All results are explained and shown in the notebooks, and should be read in the following order: 
1. dual_encoder_training
2. dual_encoder_validation
3. subtype_clustering
4. subtype_validation 
